Bioniz Therapeutics bioniz.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

Bioniz is a biopharmaceutical company leading the discovery and development of multiple-cytokine inhibitory therapeutics to address immuno-inflammatory diseases and cancer, with an initial focus on orphan diseases. Bioniz leverages expertise in cytokine biology, originating in research conducted at the National Institutes of Health, to create a therapeutic platform and a new generation of multiple-cytokine inhibitors with selective specificity. Selective targeting of multiple cytokines that have...Show all

Bioniz is a biopharmaceutical company leading the discovery and development of multiple-cytokine inhibitory therapeutics to address immuno-inflammatory diseases and cancer, with an initial focus on orphan diseases. Bioniz leverages expertise in cytok...Show all

Company (Acquired)

Phone: 949-273-6000

Fax:

5 Mason St.
Suite 200
Irvine, 92618
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Bioniz Therapeutics $27.1M Jan 8, 2020

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Bioniz Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Selective peptide antagonists Apr 27, 2018 Dec 01, 2020 Patent
Peptide conjugates Apr 19, 2018 Oct 20, 2020 Patent
Method of designing a peptide and/or peptide derivative for modulating gamma-c-cytokine activity Mar 30, 2017 Mar 12, 2019 Patent
Modulating gamma-c-cytokine activity May 03, 2017 Jul 24, 2018 Patent
Modulating gamma-c-cytokine activity Oct 06, 2016 Jul 24, 2018 Patent
See all 14 patents